VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 118 filers reported holding VIKING THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.31 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $19,393,467 | -39.9% | 1,751,894 | -11.9% | 0.01% | -37.5% |
| Q2 2023 | $32,243,635 | +43869.4% | 1,989,120 | -54.8% | 0.02% | -61.9% |
| Q1 2023 | $73,332 | +60.2% | 4,404,296 | -9.5% | 0.04% | +68.0% |
| Q4 2022 | $45,771 | -99.5% | 4,869,200 | +56.9% | 0.02% | +400.0% |
| Q3 2022 | $8,440,000 | +122.1% | 3,103,031 | +136.0% | 0.01% | +150.0% |
| Q2 2022 | $3,800,000 | -15.7% | 1,314,756 | -12.5% | 0.00% | 0.0% |
| Q1 2022 | $4,506,000 | +376.3% | 1,501,886 | +630.3% | 0.00% | – |
| Q4 2021 | $946,000 | +154.3% | 205,650 | +247.3% | 0.00% | – |
| Q3 2021 | $372,000 | +30.1% | 59,208 | +24.2% | 0.00% | – |
| Q2 2021 | $286,000 | +40.2% | 47,676 | +35.9% | 0.00% | – |
| Q3 2020 | $204,000 | -92.9% | 35,091 | -91.2% | 0.00% | -100.0% |
| Q2 2020 | $2,889,000 | +1207.2% | 400,694 | +748.1% | 0.00% | – |
| Q1 2020 | $221,000 | -81.0% | 47,247 | -72.1% | 0.00% | -100.0% |
| Q3 2019 | $1,163,000 | +83.4% | 169,070 | +103.9% | 0.00% | +100.0% |
| Q4 2018 | $634,000 | -90.1% | 82,900 | -77.6% | 0.00% | -87.5% |
| Q3 2018 | $6,435,000 | -8.4% | 369,416 | -50.1% | 0.01% | -11.1% |
| Q2 2018 | $7,028,000 | +14.9% | 740,604 | -47.1% | 0.01% | +12.5% |
| Q1 2018 | $6,115,000 | +114.3% | 1,399,370 | +99.1% | 0.01% | +100.0% |
| Q4 2017 | $2,854,000 | – | 702,972 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| APIS CAPITAL ADVISORS, LLC | 148,000 | $1,638,360 | 2.12% |
| Sio Capital Management, LLC | 595,002 | $6,586,672 | 2.04% |
| 5AM Venture Management, LLC | 585,000 | $6,475,950 | 1.86% |
| Artia Global Partners LP | 383,580 | $4,246,231 | 1.76% |
| Integral Health Asset Management, LLC | 800,000 | $8,856,000 | 1.23% |
| Boxer Capital, LLC | 2,000,000 | $22,140,000 | 1.18% |
| DAFNA Capital Management LLC | 319,655 | $3,538,581 | 1.10% |
| Affinity Asset Advisors, LLC | 332,600 | $3,681,882 | 1.04% |
| MPM BioImpact LLC | 325,000 | $3,597,750 | 0.96% |
| Affinity Asset Advisors, LLC | 300,000 | $3,321,000 | 0.93% |